Breast Tissue Epigenetic Age Clocks Predict Cancer-Risk Metabolic Markers
Researchers measured DNA methylation patterns in normal breast tissue from 91 cancer-free women using five different epigenetic age clocks, finding that Grim-m…
Found 1136 results for "cancer"
Researchers measured DNA methylation patterns in normal breast tissue from 91 cancer-free women using five different epigenetic age clocks, finding that Grim-m…
Two sophisticated imaging technologies could fundamentally transform how physicians detect, stage, and treat advanced prostate cancer, potentially improving su…
Pancreatic cancer's notorious resistance to treatment may finally face a meaningful challenge. With five-year survival rates below 12%, this malignancy represe…
Pancreatic cancer's notorious resistance to treatment may finally face a formidable challenge. The disease kills roughly 50,000 Americans annually, with most p…
The intersection of genetic risk factors may fundamentally alter how clinicians assess breast cancer susceptibility in men, particularly those developing the d…
Pancreatic ductal adenocarcinoma remains one of medicine's most formidable challenges, with five-year survival rates below 10% and limited therapeutic options…
Chronic stress wreaks havoc on multiple body systems simultaneously, but medicine has lacked precise tools to measure this cumulative damage before diseases ma…
The persistence of aggressive breast cancer patterns in Black women demands urgent attention from both clinicians and patients navigating early detection strat…
Triple-negative breast cancer represents one of the most aggressive malignancies, with limited treatment options and high metastatic potential that devastates…
Glioblastoma represents medicine's most formidable oncological challenge, with median survival rarely exceeding 15 months despite aggressive treatment. The can…
Four plant compounds—curcumin, resveratrol, epigallocatechin gallate (EGCG), and genistein—demonstrate the ability to disrupt cancer stem cell (CSC) signaling…
Analysis of 4 million breast cancer survivors reveals that GLP-1 receptor agonists emerge as a promising intervention beyond traditional lifestyle modification…
Cost barriers to cancer immunotherapy may have met their match through a dosing strategy that dramatically reduces expense while preserving clinical benefit. T…
Blood cancer patients face a critical window where molecular traces of disease predict impending relapse, yet standard surveillance offers little intervention.…
The nuclear protein YTHDC1 directly binds to m6A-modified TERT mRNA transcripts, stabilizing telomerase expression and preventing telomere shortening in ovaria…
Childhood neuroblastoma diagnosis could become more precise and accessible as artificial intelligence proves capable of identifying cancer spread through routi…
Women with hormone-positive metastatic breast cancer face critical treatment decisions after initial chemotherapy stabilizes their disease. The choice of maint…
Pancreatic cancer remains one of oncology's most formidable challenges, with five-year survival rates below 12% and limited treatment options once first-line t…
Precision medicine has taken another significant leap forward with compelling evidence that targeting specific genetic drivers before cancer spreads could fund…
Men facing aggressive prostate cancer surgery now have compelling evidence for a treatment approach that could dramatically reduce their chances of disease rec…